Skip to content
Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc.

VYGRNASDAQStock Fundamentals

Voyager Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alfred W. Sandrock Jr., with a market cap of $209.1M.

Market Cap$209.1M
Employees162.0
CEOAlfred W. Sandrock Jr.
United States of America flag
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View report
Next EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc. FAQ

Common questions about Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc. (VYGR) has a market capitalization of $209.1M and trades on NASDAQ.

Voyager Therapeutics, Inc. has approximately 162 employees.